-
1
-
-
0028947460
-
Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
-
Läi JL, Zandecki M, Mary JY, et al: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497, 1995
-
(1995)
Blood
, vol.85
, pp. 2490-2497
-
-
Läi, J.L.1
Zandecki, M.2
Mary, J.Y.3
-
2
-
-
0035496928
-
Hypodiploidy is a major prognostic factor in multiple myeloma
-
Smadja NV, Bastard C, Brigaudeau C, et al: Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98:2229-2238, 2001
-
(2001)
Blood
, vol.98
, pp. 2229-2238
-
-
Smadja, N.V.1
Bastard, C.2
Brigaudeau, C.3
-
3
-
-
0031035918
-
Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations
-
Calasanz MJ, Cigudosa JC, Odero MD, et al: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93, 1997
-
(1997)
Genes Chromosomes Cancer
, vol.18
, pp. 84-93
-
-
Calasanz, M.J.1
Cigudosa, J.C.2
Odero, M.D.3
-
4
-
-
0030792866
-
The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization
-
Nishida K, Tamura A, Nakazawa N, et al: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526-534, 1997
-
(1997)
Blood
, vol.90
, pp. 526-534
-
-
Nishida, K.1
Tamura, A.2
Nakazawa, N.3
-
5
-
-
0343355828
-
High incidence of translocations t (11;14) (q13;q32) and t (4; 14) (p16;q32) in patients with plasma cell malignancies
-
Avet-Loiseau H, Li JY, Facon T, et al: High incidence of translocations t (11;14) (q13;q32) and t (4; 14) (p16;q32) in patients with plasma cell malignancies. Cancer Res 58:5640-5645, 1998
-
(1998)
Cancer Res
, vol.58
, pp. 5640-5645
-
-
Avet-Loiseau, H.1
Li, J.Y.2
Facon, T.3
-
6
-
-
0141481984
-
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
-
Fonseca R, Debes-Marun CS, Picken EB, et al: The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Blood 102:2562-2567, 2003
-
(2003)
Blood
, vol.102
, pp. 2562-2567
-
-
Fonseca, R.1
Debes-Marun, C.S.2
Picken, E.B.3
-
7
-
-
0032147210
-
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventionaldose chemotherapy
-
Drach J, Ackermann J, Fritz E, et al: Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventionaldose chemotherapy. Blood 92:802-809, 1998
-
(1998)
Blood
, vol.92
, pp. 802-809
-
-
Drach, J.1
Ackermann, J.2
Fritz, E.3
-
8
-
-
33847378314
-
Genetic abnormalities and survival in multiple myeloma: The experience of the Intergroupe Francophone du MyéLome
-
Avet-Loiseau H, Attal M, Moreau P, et al: Genetic abnormalities and survival in multiple myeloma: The experience of the Intergroupe Francophone du Myélome. Blood 109:3489-3495, 2007
-
(2007)
Blood
, vol.109
, pp. 3489-3495
-
-
Avet-Loiseau, H.1
Attal, M.2
Moreau, P.3
-
9
-
-
22044440425
-
Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma
-
Bergsagel PL, Kuehl WM, Zhan F, et al: Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma. Blood 106:296-303, 2005
-
(2005)
Blood
, vol.106
, pp. 296-303
-
-
Bergsagel, P.L.1
Kuehl, W.M.2
Zhan, F.3
-
10
-
-
0036493522
-
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
-
Zhan F, Hardin J, Kordsmeier B, et al: Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99:1745-1757, 2002
-
(2002)
Blood
, vol.99
, pp. 1745-1757
-
-
Zhan, F.1
Hardin, J.2
Kordsmeier, B.3
-
11
-
-
10744221725
-
Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
-
Magrangeas F, Nasser V, Avet-Loiseau H, et al: Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease. Blood 101:4998-5006, 2003
-
(2003)
Blood
, vol.101
, pp. 4998-5006
-
-
Magrangeas, F.1
Nasser, V.2
Avet-Loiseau, H.3
-
12
-
-
33745779502
-
The molecular classification of multiple myeloma
-
Zhan F, Huang Y, Colla S, et al: The molecular classification of multiple myeloma. Blood 108:2020-2028, 2006
-
(2006)
Blood
, vol.108
, pp. 2020-2028
-
-
Zhan, F.1
Huang, Y.2
Colla, S.3
-
13
-
-
77957733923
-
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
-
Broyl A, Hose D, Lokhorst H, et al: Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood 116:2543-2553, 2010
-
(2010)
Blood
, vol.116
, pp. 2543-2553
-
-
Broyl, A.1
Hose, D.2
Lokhorst, H.3
-
14
-
-
54249092519
-
Predictionof survivalinmultiple myeloma based ongene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: A study of the Intergroupe Francophone du MyéLome
-
Decaux O, Lodé L, Magrangeas F, et al: Predictionof survivalinmultiple myeloma based ongene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: A study of the Intergroupe Francophone du Myélome. J Clin Oncol 26:4798-4805, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 4798-4805
-
-
Decaux, O.1
Lodé, L.2
Magrangeas, F.3
-
15
-
-
33645769276
-
Highresolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients
-
Carrasco DR, Tonon G, Huang Y, et al: Highresolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients. Cancer Cell 9:313-325, 2006
-
(2006)
Cancer Cell
, vol.9
, pp. 313-325
-
-
Carrasco, D.R.1
Tonon, G.2
Huang, Y.3
-
16
-
-
74549190701
-
Prognostic significance of copy-number alterations in multiple myeloma
-
Avet-Loiseau H, Li C, Magrangeas F, et al: Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol 27:4585-4590, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 4585-4590
-
-
Avet-Loiseau, H.1
Li, C.2
Magrangeas, F.3
-
17
-
-
34248201056
-
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
-
Chng WJ, Kumar S, Vanwier S, et al: Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 67:2982-2989, 2007
-
(2007)
Cancer Res
, vol.67
, pp. 2982-2989
-
-
Chng, W.J.1
Kumar, S.2
Vanwier, S.3
-
18
-
-
0030922231
-
Frequent translocation t (4;14) (p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
-
Chesi M, Nardini E, Brents LA, et al: Frequent translocation t (4;14) (p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260-264, 1997
-
(1997)
Nat Genet
, vol.16
, pp. 260-264
-
-
Chesi, M.1
Nardini, E.2
Brents, L.A.3
-
19
-
-
0032212243
-
The t (4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
-
Chesi M, Nardini E, Lim RS, et al: The t (4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025-3034, 1998
-
(1998)
Blood
, vol.92
, pp. 3025-3034
-
-
Chesi, M.1
Nardini, E.2
Lim, R.S.3
-
20
-
-
0031839633
-
Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma
-
Chesi M, Bergsagel PL, Shonukan OO, et al: Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457-4463, 1998
-
(1998)
Blood
, vol.91
, pp. 4457-4463
-
-
Chesi, M.1
Bergsagel, P.L.2
Shonukan, O.O.3
-
21
-
-
1442285889
-
Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
-
Hurt EM, Wiestner A, Rosenwald A, et al: Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 5:191-199, 2004
-
(2004)
Cancer Cell
, vol.5
, pp. 191-199
-
-
Hurt, E.M.1
Wiestner, A.2
Rosenwald, A.3
-
22
-
-
0034935624
-
Ectopic expression of MAFB gene in human myeloma cells carrying (14;20) (q32;q11) chromosomal translocations
-
Hanamura I, Iida S, Akano Y, et al: Ectopic expression of MAFB gene in human myeloma cells carrying (14;20) (q32;q11) chromosomal translocations. Jpn J Cancer Res 92:638-644, 2001
-
(2001)
Jpn J Cancer Res
, vol.92
, pp. 638-644
-
-
Hanamura, I.1
Iida, S.2
Akano, Y.3
-
23
-
-
0035412392
-
Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma
-
Shaughnessy J Jr, Gabrea A, Qi Y, et al: Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma. Blood 98:217-223, 2001
-
(2001)
Blood
, vol.98
, pp. 217-223
-
-
Shaughnessy, J.1
Gabrea, A.2
Qi, Y.3
-
24
-
-
84951335681
-
Understanding the role of hyperdiploidy in myeloma prognosis: Which trisomies really matter?
-
Chretien ML, Corre J, Lauwers-Cances V, et al: Understanding the role of hyperdiploidy in myeloma prognosis: Which trisomies really matter? Blood 126:2713-2719, 2015
-
(2015)
Blood
, vol.126
, pp. 2713-2719
-
-
Chretien, M.L.1
Corre, J.2
Lauwers-Cances, V.3
-
25
-
-
84895803630
-
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: The IFM experience on 1195 patients
-
Hebraud B, Leleu X, Lauwers-Cances V, et al: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: The IFM experience on 1195 patients. Blood 28:675-679, 2014
-
(2014)
Blood
, vol.28
, pp. 675-679
-
-
Hebraud, B.1
Leleu, X.2
Lauwers-Cances, V.3
-
26
-
-
33748196399
-
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: Incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
-
Hanamura I, Stewart JP, Huang Y, et al: Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: Incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood 108:1724-1732, 2006
-
(2006)
Blood
, vol.108
, pp. 1724-1732
-
-
Hanamura, I.1
Stewart, J.P.2
Huang, Y.3
-
27
-
-
78149246124
-
Mutations in TP53 are exclusively associated with del (17p) in multiple myeloma
-
Lodé L, Eveillard M, Trichet V, et al: Mutations in TP53 are exclusively associated with del (17p) in multiple myeloma. Haematologica 95:1973-1976, 2010
-
(2010)
Haematologica
, vol.95
, pp. 1973-1976
-
-
Lodé, L.1
Eveillard, M.2
Trichet, V.3
-
28
-
-
84962219514
-
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
-
Liu Y, Chen C, Xu Z, et al: Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature 531:471-475, 2016
-
(2016)
Nature
, vol.531
, pp. 471-475
-
-
Liu, Y.1
Chen, C.2
Xu, Z.3
-
29
-
-
84951020021
-
Revised International Staging System for multiple myeloma: A report from International Myeloma Working Group
-
Palumbo A, Avet-Loiseau H, Oliva S, et al: Revised International Staging System for multiple myeloma: A report from International Myeloma Working Group. J Clin Oncol 33:2863-2869, 2015
-
(2015)
J Clin Oncol
, vol.33
, pp. 2863-2869
-
-
Palumbo, A.1
Avet-Loiseau, H.2
Oliva, S.3
-
30
-
-
79951494668
-
Initial genome sequencing and analysis of multiple myeloma
-
Chapman MA, Lawrence MS, Keats JJ, et al: Initial genome sequencing and analysis of multiple myeloma. Nature 471:467-472, 2011
-
(2011)
Nature
, vol.471
, pp. 467-472
-
-
Chapman, M.A.1
Lawrence, M.S.2
Keats, J.J.3
-
31
-
-
84892699941
-
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
-
Bolli N, Avet-Loiseau H, Wedge DC, et al: Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 5:2997, 2014
-
(2014)
Nat Commun
, vol.5
, pp. 2997
-
-
Bolli, N.1
Avet-Loiseau, H.2
Wedge, D.C.3
-
32
-
-
84892409192
-
Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy
-
Lohr JG, Stojanov P, Carter SL, et al: Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell 25:91-101, 2014
-
(2014)
Cancer Cell
, vol.25
, pp. 91-101
-
-
Lohr, J.G.1
Stojanov, P.2
Carter, S.L.3
-
33
-
-
84928558756
-
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
-
Walker BA, Wardell CP, Murison A, et al: APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun 6:6997, 2015
-
(2015)
Nat Commun
, vol.6
, pp. 6997
-
-
Walker, B.A.1
Wardell, C.P.2
Murison, A.3
-
34
-
-
79959293462
-
BRAF mutations in hairy-cell leukemia
-
Tiacci E, Trifonov V, Schiavoni G, et al: BRAF mutations in hairy-cell leukemia. N Engl J Med 364:2305-2315, 2011
-
(2011)
N Engl J Med
, vol.364
, pp. 2305-2315
-
-
Tiacci, E.1
Trifonov, V.2
Schiavoni, G.3
-
35
-
-
84865475885
-
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia
-
Treon SP, Xu L, Yang G, et al: MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med 367:826-833, 2012
-
(2012)
N Engl J Med
, vol.367
, pp. 826-833
-
-
Treon, S.P.1
Xu, L.2
Yang, G.3
-
36
-
-
84882837534
-
Signatures of mutational processes in human cancer
-
Alexandrov LB, Nik-Zainal S, Wedge DC, et al: Signatures of mutational processes in human cancer. Nature 500:415-421, 2013
-
(2013)
Nature
, vol.500
, pp. 415-421
-
-
Alexandrov, L.B.1
Nik-Zainal, S.2
Wedge, D.C.3
-
37
-
-
84885640686
-
Erratum
-
[Erratum: Nature 502:258, 2013]
-
(2013)
Nature
, vol.502
, pp. 258
-
-
-
38
-
-
84947116451
-
Mutational spectrum, copy number changes, and outcome: Results of a sequencing study of patients with newly diagnosed myeloma
-
Walker BA, Boyle EM, Wardell CP, et al: Mutational spectrum, copy number changes, and outcome: Results of a sequencing study of patients with newly diagnosed myeloma. J Clin Oncol 33:3911-3920, 2015
-
(2015)
J Clin Oncol
, vol.33
, pp. 3911-3920
-
-
Walker, B.A.1
Boyle, E.M.2
Wardell, C.P.3
-
39
-
-
84911897497
-
Differential and limited expression of mutant alleles in multiple myeloma
-
Rashid NU, Sperling AS, Bolli N, et al: Differential and limited expression of mutant alleles in multiple myeloma. Blood 124:3110-3117, 2014
-
(2014)
Blood
, vol.124
, pp. 3110-3117
-
-
Rashid, N.U.1
Sperling, A.S.2
Bolli, N.3
-
40
-
-
84873565928
-
Minor clone provides a reservoir for relapse in multiple myeloma
-
Magrangeas F, Avet-Loiseau H, Gouraud W, et al: Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia 27:473-481, 2013
-
(2013)
Leukemia
, vol.27
, pp. 473-481
-
-
Magrangeas, F.1
Avet-Loiseau, H.2
Gouraud, W.3
-
41
-
-
84864544413
-
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11;14) myeloma
-
Walker BA, Wardell CP, Melchor L, et al: Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11;14) myeloma. Blood 120:1077-1086, 2012
-
(2012)
Blood
, vol.120
, pp. 1077-1086
-
-
Walker, B.A.1
Wardell, C.P.2
Melchor, L.3
-
43
-
-
84893810104
-
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
-
Walker BA, Wardell CP, Melchor L, et al: Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia 28:384-390, 2014
-
(2014)
Leukemia
, vol.28
, pp. 384-390
-
-
Walker, B.A.1
Wardell, C.P.2
Melchor, L.3
-
44
-
-
84881490568
-
Targeting the BRAF V600E mutation in multiple myeloma
-
Andrulis M, Lehners N, Capper D, et al: Targeting the BRAF V600E mutation in multiple myeloma. Cancer Discov 3:862-869, 2013
-
(2013)
Cancer Discov
, vol.3
, pp. 862-869
-
-
Andrulis, M.1
Lehners, N.2
Capper, D.3
|